James Cook University researcher wins $2M Gates grant for malaria vaccine development

Louis Schofield, director of the Australian Institute of Tropical Health and Medicine at James Cook University, received a grant from the Bill & Melinda Gates Foundation worth AU$2.8 million ($2 million) to pursue preclinical development of a malaria vaccine. A team of researchers from North Queensland and Victoria will use the funding to develop a broad-spectrum vaccine effective against most species of human malaria. Release

Suggested Articles

Merck has a big target in mind for its pneumococcal vaccine V114: Prevnar 13, the world's best-selling shot—and its phase 3 program shows it.

A Lancet Infectious Diseases study shows antibody response persists for two years or more after a single shot of Merck’s rVSV-ZEBOV vaccine.

Behind the under-pressure blockbuster Prevnar 13 are several pipeline vaccines Pfizer hopes will propel future growth.